Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Merit Medical Systems
MMSI
$5.42B
| $43M | 0.07% |
1,014,568
+417,147
| +70% | +$16.8M |
|
|
PFPT
402
DELISTED
Proofpoint, Inc.
PFPT
| $43M | 0.07% |
492,450
+264,091
| +116% | +$23.5M |
|
403
HUB Group
HUBG
$2.49B
| $42.8M | 0.07% |
1,992,872
+530,846
| +36% | +$10.1M |
|
|
REN
404
DELISTED
Resolute Energy Corporaton
REN
| $42.6M | 0.06% |
1,434,912
+372,256
| +35% | +$11.1M |
|
405
FMC
FMC
$1.38B
| $42.4M | 0.06% |
547,622
+197,793
| +57% | +$14.2M |
|
406
AES
AES
$10.5B
| $42.4M | 0.06% |
3,847,840
+1,331,272
| +53% | +$14.9M |
|
407
Gartner
IT
$12.4B
| $42.4M | 0.06% |
340,603
-330,599
| -49% | -$40.9M |
|
408
Arthur J. Gallagher & Co
AJG
$67.6B
| $42.2M | 0.06% |
685,058
-485,342
| -41% | -$28.6M |
|
409
Dolby
DLB
$6.11B
| $42M | 0.06% |
729,472
+409,914
| +128% | +$21.5M |
|
|
RDS.B
410
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $42M | 0.06% |
670,863
+302,725
| +82% | +$17.4M |
|
411
Vishay Intertechnology
VSH
$4.85B
| $41.9M | 0.06% |
2,228,257
+1,482,036
| +199% | +$26.1M |
|
|
LGF.A
412
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $41.8M | 0.06% |
1,249,099
+1,233,444
| +7,879% | +$36.3M |
|
413
Diageo
DEO
$52.6B
| $41.6M | 0.06% |
314,900
+310,625
| +7,266% | +$40.1M |
|
414
Credit Acceptance
CACC
$6.24B
| $41.6M | 0.06% |
148,417
-30,200
| -17% | -$7.93M |
|
415
Cintas
CTAS
$81.6B
| $41.6M | 0.06% |
+1,152,036
| New | +$38.4M |
|
416
Green Plains
GPRE
$1.14B
| $41.4M | 0.06% |
2,055,174
-166,259
| -7% | -$3.17M |
|
|
HRG
417
DELISTED
HRG Group, Inc.
HRG
| $41.4M | 0.06% |
2,652,054
+119,028
| +5% | +$1.92M |
|
418
Zoetis
ZTS
$32.1B
| $41.1M | 0.06% |
644,092
-1,151,594
| -64% | -$72.1M |
|
419
Teradyne
TER
$58.7B
| $41M | 0.06% |
1,098,178
+366,111
| +50% | +$12.7M |
|
|
JOYY
420
JOYY Inc
JOYY
$3.71B
| $40.9M | 0.06% |
471,632
+117,211
| +33% | +$8.51M |
|
|
BIG
421
DELISTED
Big Lots, Inc.
BIG
| $40.7M | 0.06% |
760,290
-770,956
| -50% | -$38M |
|
422
Dentsply Sirona
XRAY
$2.18B
| $40.7M | 0.06% |
679,980
+654,840
| +2,605% | +$38.9M |
|
|
IMMU
423
DELISTED
Immunomedics Inc
IMMU
| $40.6M | 0.06% |
2,904,762
-1,314,720
| -31% | -$13.1M |
|
424
Edgewell Personal Care
EPC
$1.32B
| $40.6M | 0.06% |
558,028
+368,205
| +194% | +$27.1M |
|
|
SRCL
425
DELISTED
Stericycle Inc
SRCL
| $40.5M | 0.06% |
565,041
-514,273
| -48% | -$37.8M |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.